Literature DB >> 15345598

Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.

Seiichi Okabe1, Seiji Fukuda, Young-June Kim, Masaru Niki, Louis M Pelus, Kazuma Ohyashiki, Pier Paolo Pandolfi, Hal E Broxmeyer.   

Abstract

Events mediating stromal cell-derived factor-1 (SDF-1alpha/CXCL12) chemotaxis of lymphocytes are not completely known. We evaluated intracellular signaling through RasGAP-associated protein p62Dok-1 (downstream of tyrosine kinase [Dok-1]) and associated proteins. SDF-1alpha/CXCL12 stimulated Dok-1 tyrosine phosphorylation and association with RasGAP, adaptor protein p46Nck, and Crk-L in Jurkat T cells. The phosphorylation of Dok-1 was blocked by pretreatment of cells with the src kinase inhibitor PP2. Src kinase family member Lck was implicated. SDF-1alpha/CXCL12 did not phosphorylate Dok-1 in J.CaM1.6 cells, a Jurkat derivative not expressing Lck, but did phosphorylate Dok-1 in J.CaM1.6 cells expressing Lck. SDF-1alpha/CXCL12 induced the tyrosine phosphorylation of Pyk2 and the association of Pyk2 with zeta chain-associated protein-70 kilodaltons (Zap-70) and Vav. SDF-1alpha/CXCL12 enhanced the association of RasGAP with Pyk2. CXCR4-expressing NIH3T3 and Baf3 cells transfected with full-length Dok-1 cDNA were suppressed in their responses to SDF-1alpha/CXCL12-induced chemotaxis; mitogen-activated protein (MAP) kinase activity was also decreased. Chemotaxis to SDF-1/CXCL12 was significantly enhanced in Dok-1(-/-) CD4+ and CD8+ splenic T cells. These results implicate Dok-1, Nck, Crk-L, and Src kinases-especially Lck, Pyk2, Zap-70, Vav, and Ras-GAP-in intracellular signaling by SDF-1alpha/CXCL12, and they suggest that Dok-1 plays an important role in SDF-1alpha/CXCL12-induced chemotaxis in T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345598     DOI: 10.1182/blood-2004-03-0843

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Chemoattractant receptor signaling and the control of lymphocyte migration.

Authors:  John H Kehrl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis.

Authors:  Xian-Ming Xia; Fang-Yu Wang; Wen-An Xu; Zhen-Kai Wang; Jiong Liu; You-Ke Lu; Xin-Xin Jin; Heng Lu; Yun-Zhu Shen
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

3.  Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

Authors:  Olivia D Schneider; Alison A Weiss; William E Miller
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

4.  Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.

Authors:  Anil Prasad; Zahida Qamri; Jane Wu; Ramesh K Ganju
Journal:  J Leukoc Biol       Date:  2007-06-12       Impact factor: 4.962

5.  Persistent fetal infection with bovine viral diarrhea virus differentially affects maternal blood cell signal transduction pathways.

Authors:  Natalia P Smirnova; Andrey A Ptitsyn; Kathleen J Austin; Helle Bielefeldt-Ohmann; Hana Van Campen; Hyungchul Han; Alberto L van Olphen; Thomas R Hansen
Journal:  Physiol Genomics       Date:  2008-11-18       Impact factor: 3.107

6.  Interaction of Ras with p110γ is required for thymic β-selection in the mouse.

Authors:  Michelle L Janas; Martin Turner
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

7.  Positive and negative regulation by SLP-76/ADAP and Pyk2 of chemokine-stimulated T-lymphocyte adhesion mediated by integrin α4β1.

Authors:  Ana Dios-Esponera; Soledad Isern de Val; Silvia Sevilla-Movilla; Rosa García-Verdugo; David García-Bernal; Nohemí Arellano-Sánchez; Carlos Cabañas; Joaquin Teixidó
Journal:  Mol Biol Cell       Date:  2015-07-22       Impact factor: 4.138

Review 8.  Chemokines and their receptors in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2015-07-15       Impact factor: 4.599

9.  Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells.

Authors:  Seiichi Okabe; Tetsuzo Tauchi; Yuko Tanaka; Shinya Kimura; Taira Maekawa; Kazuma Ohyashiki
Journal:  Cancer Cell Int       Date:  2013-04-04       Impact factor: 5.722

Review 10.  MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  Front Immunol       Date:  2015-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.